Robert Deryke

Robert DeRyke is an accomplished executive with extensive experience in the cardiovascular sector. Currently serving as President and CEO of Terumo Cardiovascular since 2012, Robert has also held the position of President and CEO at Terumo Heart, Inc. from January 2022 to October 2023. Robert contributed to MichBio as a Board Member from September 2016 to January 2022 and previously worked in senior roles at Vesta, Baxter Healthcare, Hospira, and Thermo Fisher Scientific, where responsibilities included quality and regulatory management. Educational qualifications include an MBA from Michigan State University and a BS in Chemistry from Western Michigan University, complemented by participation in the Global CEO Program at The Wharton School, China Europe International Business School, and IESE Business School in 2017-2018.